3 March

New materials help assess medicines policies and interventions

24 February

A new (and improved) model to regulate pharmaceutical promotion

12 February

Enhancing accountability in the medicines market: The Medicines Transparency Alliance

31 January

Bayer CEO's callous comments highlight failure of current biomedical innovation model

25 November

When politicians go to the movies

12 July

DG Trade State of Play reveals EU's ambitions for IP protection in FTAs